77 related articles for article (PubMed ID: 3265023)
1. [Effects of pre-instilled mydriatics on the intraocular concentration and anti-inflammatory action of topical 0.1% pranoprofen].
Ogawa T; Ohara K; Ohira M
Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1510-9. PubMed ID: 3265023
[No Abstract] [Full Text] [Related]
2. [Effects of pre-instilled mydriatics on the intraocular concentration and anti-inflammatory action of topical 0.1% pranoprofen (2)--Study on multiple dosing].
Ogawa T; Ohara K; Shimizu H
Nippon Ganka Gakkai Zasshi; 1992 Sep; 96(9):1079-84. PubMed ID: 1414697
[TBL] [Abstract][Full Text] [Related]
3. [Effects of pre-instilled mydriatics on the intraocular concentration and anti-inflammatory action of topical 0.1% pranoprofen (3)--study on permeability factor].
Ogawa T; Ohara K; Shimizu H
Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1379-86. PubMed ID: 1476068
[TBL] [Abstract][Full Text] [Related]
4. Effects of pretreatment with mydriatics on intraocular penetration of 0.1% pranoprofen.
Ogawa T; Ohara K; Shimizu H
Jpn J Ophthalmol; 1993; 37(1):47-55. PubMed ID: 8320865
[TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
[TBL] [Abstract][Full Text] [Related]
6. In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration.
Cañadas C; Alvarado H; Calpena AC; Silva AM; Souto EB; García ML; Abrego G
Int J Pharm; 2016 Sep; 511(2):719-27. PubMed ID: 27480398
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective disposition of pranoprofen, a nonsteroidal antiinflammatory drug, in rabbits.
Nomura T; Imai T; Otagiri M
Biol Pharm Bull; 1993 Mar; 16(3):298-303. PubMed ID: 8364476
[TBL] [Abstract][Full Text] [Related]
8. Species differences in absorption, metabolism and excretion of pranoprofen, a 2-arylpropionic acid derivative, in experimental animals.
Arima N; Kato Y
J Pharmacobiodyn; 1990 Dec; 13(12):739-44. PubMed ID: 2098547
[TBL] [Abstract][Full Text] [Related]
9. The concurrent application of ophthalmic drops.
Geyer O; Godel V; Lazar M
Aust N Z J Ophthalmol; 1985 Feb; 13(1):63-6. PubMed ID: 4015882
[TBL] [Abstract][Full Text] [Related]
10. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
Stadtbäumer K; Frommlet F; Nell B
Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
[TBL] [Abstract][Full Text] [Related]
11. Methods for increasing bioavailability of cycloplegics.
McGraw BF; Rollins CL
Am J Optom Physiol Opt; 1978 Dec; 55(12):795-800. PubMed ID: 753105
[TBL] [Abstract][Full Text] [Related]
12. [Analgesic effect of topically applied pranoprofen-gel].
Terasawa M; Yakushiji T; Iwahisa Y; Imayoshi T; Maruyama Y
Nihon Yakurigaku Zasshi; 1985 Dec; 86(6):433-40. PubMed ID: 3879232
[TBL] [Abstract][Full Text] [Related]
13. Probenecid-induced changes in the clearance of pranoprofen enantiomers.
Imai T; Nomura T; Otagiri M
Chirality; 2003 May; 15(4):318-23. PubMed ID: 12666238
[TBL] [Abstract][Full Text] [Related]
14. Effect of tropicamide on ocular blood flow in the rabbit.
Delgado D; Michel P; Jaanus SD
Am J Optom Physiol Opt; 1982 May; 59(5):410-2. PubMed ID: 7102799
[TBL] [Abstract][Full Text] [Related]
15. [Effect of topical pranoprofen on the lipoxygenase metabolism of the arachidonic and in endotoxin-induced uveitis].
Torrón C; Ferrer E; Ruiz-Moreno O; Cuevas R; Pérez S; Alabart JL; Honrubia FM
Arch Soc Esp Oftalmol; 2000 Jun; 75(6):377-82. PubMed ID: 11151181
[TBL] [Abstract][Full Text] [Related]
16. The influence of fever on the pharmacokinetics of pranoprofen in elderly subjects.
Fujimura A; Kajiyama H; Ebihara A
J Clin Pharmacol; 1989 Jun; 29(6):500-3. PubMed ID: 2787808
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of pranoprofen gel for percutaneous administration.
Choi JS; Shin SC
Drug Dev Ind Pharm; 2007 Jan; 33(1):19-26. PubMed ID: 17192247
[TBL] [Abstract][Full Text] [Related]
18. Proceedings: Anti-inflammatory activity of 2-(5H-(1)benzopyrano(2,3-b) pyridin-7-yl) propionic acid (Y-8004).
Nakanishi M; Maruyama Y; Terasawa M; Anami K
Jpn J Pharmacol; 1974; 24(0):s:140. PubMed ID: 4545994
[No Abstract] [Full Text] [Related]
19. Comparative evaluation of topical pranoprofen and fluorometholone in cases with chronic allergic conjunctivitis.
Li Z; Mu G; Chen W; Gao L; Jhanji V; Wang L
Cornea; 2013 May; 32(5):579-82. PubMed ID: 23023407
[TBL] [Abstract][Full Text] [Related]
20. The effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival HLA-DR expression in dry eyes.
Liu X; Wang S; Kao AA; Long Q
Cornea; 2012 Nov; 31(11):1235-9. PubMed ID: 22677643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
